Michael A. Pisetsky, the Chief Legal Officer of SI-BONE, Inc., has sold a total of 3,133 shares of the company's common stock. This transaction, which occurred on October 2, 2026, was executed to cover tax withholding obligations related to the vesting of restricted stock units. Such actions are significant as they indicate how executives manage their equity stakes in the company.
SI-BONE, Inc. is a company that specializes in the development of innovative solutions for patients suffering from musculoskeletal disorders. The firm is categorized under the SIC code for surgical and medical instruments and apparatus. Recent filings indicate that SI-BONE has been active in the market, with multiple transactions reported over the past few months.
According to the latest filing, Pisetsky sold 1,300 shares at a price of $18.2033, 1,799 shares at $18.1418, and 34 shares at $18.14. The total shares sold were necessary to meet tax obligations associated with the vesting of restricted stock units. The filing noted, "The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units." This indicates that the sale was not a discretionary trade but a requirement for tax compliance.
Following these transactions, Pisetsky retains ownership of 270,517 shares of SI-BONE, including 124,139 shares that are issuable upon the settlement of restricted stock units. This continued ownership reflects his ongoing commitment to the company and its future performance.
The impact of this transaction may resonate across the surgical and medical instruments industry, as other executives and stakeholders observe how leaders manage their stock holdings in light of tax obligations. Such transactions can influence investor sentiment and perceptions of corporate governance.
As for what’s next, the filing does not specify any upcoming events or further transactions. However, stakeholders may continue to monitor SI-BONE for additional updates regarding executive transactions and company performance.











